Platform|API|Archive|Contact
Humanexa SignalsPharmaceutical Intelligence
Subscribe
Signals
Regulatory
  • FDA
  • EMA
  • MHRA
  • PMDA
  • Health Canada
Clinical
  • Phase I
  • Phase II
  • Phase III
  • Readouts
  • Enrollment Signals
Competitive
  • Pipeline Tracking
  • Company Moves
  • Asset Intelligence
  • Landscape Reports
Markets
  • Pricing
  • Access
  • Commercial
  • Launch Tracking
M&A Watch
  • Licensing
  • Acquisitions
  • Partnerships
  • Capital Raises
StrategyCatalystsPricing
Humanexa Signals

Data-driven pharmaceutical intelligence for biotech investors, pharma operators, consultants, and intelligence teams.

Powered by Humanexa

Categories

  • Regulatory
  • Clinical
  • Competitive
  • Markets
  • M&A Watch
  • Strategy
  • Catalyst Tracker

Company

  • Pricing
  • Partner with us
  • Subscribe
  • Contact
  • Privacy

Subscribe to Humanexa Signals

Weekly intelligence for pharma decision-makers.

No paywall. No spam. Unsubscribe anytime.

© 2026 Humanexa Signals. All rights reserved.

Intelligence powered by the Humanexa engine.

  1. Home
  2. /Clinical
  3. /Enrollment Signals

Clinical

Enrollment Signals(4)

Follow pivotal data releases and trial developments that create new strategic pressure for biotech and pharma operators.

4 signals

ScoreIntelligence Record
7.0

CLINICAL

Expanded Access Study for Bulevirtide in Chronic Hepatitis Delta Virus Infection

An expanded access study for bulevirtide aims to provide treatment to eligible patients with chronic hepatitis delta virus infection.

Expanded·July 30, 2026
6.0

CLINICAL

Trial to Assess Recruitment Methods for Type 1 Diabetes Screening

A clinical trial is evaluating the effectiveness of different recruitment communication methods for type 1 diabetes screening.

Sanofi·Trial·July 23, 2026
7.0

CLINICAL

MyeloMATCH Screening Study to Enhance Treatment Matching for Myeloid Cancer Patients

The MyeloMATCH study aims to improve patient enrollment in clinical trials for myeloid cancers by using biomarker testing.

July 13, 2026
7.0

CLINICAL

Study on Obesity and Heart Disease Risk Factors in African Americans Launched

A new study aims to explore the relationship between obesity and heart disease risk factors in African American men and women, focusing on body size and sex differences.

pharmaceutical companies targeting cardiovascular diseases·Study·June 22, 2026

Showing 1–4 of 4 records

Newsletter

Get signals before the market moves

Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.

No paywall. No spam. Unsubscribe anytime.